Jeremy is a Director and founder of Cofactor Group. His 20+ years of healthcare experience includes leading engagements in opportunity assessment and lifecycle strategy, forecasting, brand strategy, market access strategy, and launch planning. He has experience in all major therapeutic categories, including Oncology, Respiratory, Cardiovascular, CNS, and Rare Diseases.
Prior to founding Cofactor Group, Jeremy was a consultant in the Health Care Practice and Arthur D. Little, a global strategy consulting firm. Jeremy holds a Bachelor of Arts in Molecular Biology from Princeton University and a Master of Science in Molecular and Cellular Biology from the University of Pennsylvania.
Cofactor partnered with a biotechnology organization to inform critical investment decisions about a potential treatment for SARS-CoV-2 infection.
Co-commercialization or co-promotion agreements have become the new norm in the life sciences industry, and all have one thing in common - they are challenging. Cofactor provides specific alliance expertise, capabilities, and tools that can help your alliance work more effectively.